Focus On Alumni With Maria Nakafeero

Maria Nakafeero, 28, recently graduated from the Master’s of Public Health Program within UC’s Department of Environmental Health. A Uganda native, she is the sixth out of nine living children in her family. Nakafeero received her undergraduate degree in Clinical Medicine and Community Health from Mbale School of Clinical Officers in Uganda. She came to Cincinnati through the support of a local nonprofit organization called Hope for Kabingo, which helped fundraise for her tuition and allowed her to pursue her graduate studies at UC.

What led to you receiving your master’s in public health at UC? What is your concentration?

"My MPH concentration is in Health Services Management.  I became interested in doing a MPH after experiencing firsthand the devastating impact of deaths due to preventable causes like malaria, diarrhea and pneumonia among the people in my village including some of my siblings.”

What are some of the most valuable or important things you learned through the program? What would you tell other students?

"Valuable skills that I have learned in my program include but are not limited to analytical skills, critical thinking skills, writing skills, the significance of evidence and best practices in advancing public health and finally how to work with the rest of the stakeholders, including the community and political leaders, to improve the health of the public.

"I would tell the rest of the students to take time to synthesize the classroom material so that its relevance goes beyond just grades. I am also planning to sit for my Certificate in Public Health (CPH) exam, an accreditation by the National Board of Public Health Examiners. I would encourage fellow students to consider taking that certification too.”

We've heard that you'll be returning to Uganda and helping with a clinical trial there. Could you tell us more about the organization and how you will use your training? Also, could you share more about the clinical trial?

"I will be working with Global Health Uganda, in collaboration with Cincinnati Children’s Hospital Medical Center and Indiana University, on a clinical trial called the Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM) as a Research Coordinator.

"I will have two important roles:  First, as the main Transcranial Doppler (TCD) examiner, carrying out TCD exams that are used to assess the potential risk for stroke among NOHARM study participants; second, collecting blood samples for hydroxyurea pharmacokinetics in the children. 

"NOHARM is a first of its kind clinical trial to investigate the safety and efficacy of hydroxyurea for children with sickle cell anemia in a malaria endemic region within sub-Saharan Africa. The study will be able to provide important evidence-based information to help improve the care and treatment of individuals with sickle cell in Uganda. 

"Global Health Uganda is a multi-disciplinary research corporation conducting research on a wide range of topics including sickle cell anemia and neurodevelopmental outcomes in children with severe malaria among others.

"The various courses in my training, for example ‘Evidence Based Public Health,’ ‘Biostatistics,’ ‘Epidemiology’ and others have set a stage for me to understand my job well. And much of the major part of my job is carrying out these tests, like the TCD exams and pharmacokinetic blood draws. The critical thinking skills that I have learned will be essential for me to know why I am doing, what I am doing. In addition with my MPH training, I know the relevance of accuracy and paying attention to detail and protocol as I conduct these tests. This will enable me to avoid any errors due to negligence.”

What do you like to do in your spare time? What are some hobbies or likes outside of your passion for global health?

"My hobbies include listening to music, watching movies, spending time with friends and praying.”

Tags

Related Stories

2

At least two weather patterns increase headaches, UC study suggests

June 4, 2026

University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.